Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05646511
What this trial is testing

TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
National Cancer Center Hospital East 608
Testing effectiveness (Phase 2)Looking for participantsNCT05378919
What this trial is testing

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
Lithuanian University of Health Sciences 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06872606
What this trial is testing

Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer

Who this might be right for
Rectal Adenocarcinoma
Sir Run Run Shaw Hospital 33
Not applicableAvailableNCT07614048
What this trial is testing

Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaColorectal Cancer
Providence Health & Services
Testing effectiveness (Phase 2)UnknownNCT04866108
What this trial is testing

A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Beijing Friendship Hospital 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05673772
What this trial is testing

Preoperative Sequential Short-course Radiation Therapy and FOLFOX for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Kyungpook National University Hospital 364
Testing effectiveness (Phase 2)UnknownNCT02603302
What this trial is testing

Radiation Dose Escalation in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
University of Brasilia 48
Testing effectiveness (Phase 2)Looking for participantsNCT07718490
What this trial is testing

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 43
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Testing effectiveness (Phase 2)Study completedNCT00034619
What this trial is testing

Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Eli Lilly and Company
Large-scale testing (Phase 3)Study completedNCT00393822
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Who this might be right for
Colon Cancer
Amgen 100
Not applicableEnded earlyNCT02560740
What this trial is testing

The Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy

Who this might be right for
Colorectal CancerAdvanced Gastric CancerNeuropathy
SMR Biotech Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT06943820
What this trial is testing

AK129 Combination Therapy for Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVHead and Neck Squamous Cell Carcinoma (HNSCC)Colorectal Adenocarcinoma+1 more
Akeso 230
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Not applicableUnknownNCT04227886
What this trial is testing

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Who this might be right for
Rectal Neoplasm Malignant CarcinomaChemoradiotherapyNeoadjuvant Therapy+2 more
Fudan University 250
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Early research (Phase 1)Looking for participantsNCT06065371
What this trial is testing

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Who this might be right for
Gastrointestinal Cancer
Henry Ford Health System 20
Testing effectiveness (Phase 2)UnknownNCT02942563
What this trial is testing

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
RenJi Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00021398
What this trial is testing

Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center 23
Next Page